Skip to content
Search AI Powered

Latest Stories

Challenging titles: Taking BMA's lead PDA raises concerns over the term 'pharmacy professionals'

Challenging titles: Taking BMA's lead PDA raises concerns over the term 'pharmacy professionals'
The PDA recognises the similarities between the unwelcome use by the government and others of the terms ‘medical professionals’ in medicine, and ‘pharmacy professionals’ in pharmacy

A judicial review claim launched by the British Medical Association (BMA) against the General Medical Council (GMC) has parallelly intensified Pharmacists' Defence Association's (PDA) scrutiny over the use of the term 'pharmacy professionals'.

PDA has criticised the evolving definition of 'pharmacy professionals,' and the potential risks to patient safety amidst regulatory ambiguity as part of "a far wider agenda."


Concerns stem from what the PDA perceives as a blurring of distinctions between pharmacists and pharmacy technicians as "attempted homogenisation"  by bodies like the General Pharmaceutical Council (GPhC), NHS, and Royal Pharmaceutical Society (RPS).

Raising similar issue as the BMA against the GMC over its use of 'medical professionals for  doctors and Medical Associate Professions (MAPs), Mark Koizol, Chairman of the PDA has said:

"What we are concerned about is a much more dangerous, planned, and strategic direction which impacts upon the safety of patients."

Distinguishing between the role of a pharmacy technician and a pharmacist, the PDA has said that:

"Pharmacy technicians have either completed an NVQ level 3 course or, in most cases were simply added to the GPhC register via a grandparenting route.

"Pharmacy technicians do not participate in a final registration assessment."

Whereas, pharmacists need to graduate "from a four-year university MPharm course followed by a year of supervised foundation training" to then pass a final registration assessment to qualify as a pharmacist.

"As a result, these two pharmacy roles have very different requirements for their underpinning knowledge, competence, and the final quality assurance process before registration," the statement said.

A recurring problem

In December 2023, the GPhC publicly apologised for erroneously referring to pharmacy technicians as 'pharmacists technician'.

This incident highlighted concerns over accurate professional titles and their impact on patient safety and public protection, an issue underscored by the Professional Standards Authority (PSA) on its website.

The PDA claims that they have already written to the GPhC and recently questioned the pharmacy minister, Dame Andrea Leadsom over safety concerns due to "the blurring of the lines between pharmacists and pharmacy technicians but has not received a satisfactory response."

Moreover, when questioned about the use of pharmacy technicians by the Health Select Committee in its Inquiry into Pharmacy, the pharmacy minister gave a defensive response and did not provide "any real assurances on patient safety."

The association has also criticised pharmacists who "continue to participate in this blurring of the lines between roles are doing nothing more than colluding in the demise of their own profession".

"Other professions have already started to challenge the government through the courts and soon the time may come for pharmacists to do the same.," said Koizol.

"The PDA will watch the two existing legal challenges about the use of the phrase ‘medical professionals’ closely to consider what aspects of those cases might be used to challenge the use of the term ‘pharmacy professionals.”

More For You

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

Chronic inflammation is linked to more than 50 per cent of all deaths worldwide and one in five cancers.

The Complete Anti-Inflammatory Guide - a useful resource for pharmacists to support patient health and wellbeing

When Hemant Patel was struck down by Covid, he was determined to discover what was it that led to the disease having a devastating impact on the lives of people who seemed be healthy – the culmination of his journey is the book, The Complete Anti-Inflammatory Guide.

“I was gasping for breath and counting the number of days I might be alive when I was infected with Covid,” reveals Patel.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less